Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07019272 | Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study | not yet recruiting | — | 170 | Hebei Medical University Fourth HospitalOTHER | 0 | Jun 13, 2025 | clinicaltrials |
| NCT07019337 | Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer | not yet recruiting | Phase 2 | 100 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER |
| 0 |
| Jun 13, 2025 |
| clinicaltrials |
| NCT07020962 | Effect of Laughter Therapy on Breast Cancer Patients | not yet recruiting | N/A | 56 | Prof. Dr. Cemil Tascıoglu Education and Research Hospital OrganizationOTHER | 0 | Jun 13, 2025 | clinicaltrials |
| NCT07021261 | Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients | not yet recruiting | Phase 3 | 440 | Fudan UniversityOTHER | 0 | Jun 13, 2025 | clinicaltrials |
| NCT07017530 | Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment(CHEMO-CogEx) | not yet recruiting | N/A | 220 | Universidad de ExtremaduraOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT07018505 | EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers | not yet recruiting | — | 40 | Yunnan Cancer HospitalOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT07011823 | Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC(KEY-MELT) | not yet recruiting | Phase 2 | 20 | Gangnam Severance HospitalOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT07012707 | Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy | not yet recruiting | — | 172 | Peking Union Medical College HospitalOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT07005557 | Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer(SENIOR) | not yet recruiting | Phase 3 | 1,244 | Fudan UniversityOTHER | 0 | Jun 5, 2025 | clinicaltrials |
| NCT07005583 | Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer | not yet recruiting | Phase 2 | 46 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06786585 | Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol | not yet recruiting | — | 600 | Eastern Cooperative Oncology GroupNETWORK | 0 | May 30, 2025 | clinicaltrials |
| NCT06996093 | Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor | not yet recruiting | Phase 3 | 2,508 | Fudan UniversityOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06309615 | Decision Impact Study of PreciseDx Breast(PDxBRUTILITY) | not yet recruiting | — | 300 | Precise Dx, Inc.INDUSTRY | 0 | May 29, 2025 | clinicaltrials |
| NCT06994078 | Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors | not yet recruiting | N/A | 56 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06993246 | Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?(CEM) | not yet recruiting | N/A | 50 | Jean SeelyOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06990165 | Photobiomodulation in Radiodermatitis in People With Breast Cancer | not yet recruiting | N/A | 148 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | May 25, 2025 | clinicaltrials |
| NCT06975644 | Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC) | not yet recruiting | N/A | 55 | Zhejiang Provincial People's HospitalOTHER | 0 | May 22, 2025 | clinicaltrials |
| NCT06981182 | EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults(EQUITA) | not yet recruiting | N/A | 300 | University of SunderlandOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06977412 | The Application Value of Spectral CT in the Accurate Staging of Breast Cancer | not yet recruiting | N/A | 150 | Yunnan Cancer HospitalOTHER | 0 | May 18, 2025 | clinicaltrials |
| NCT06977542 | Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer | not yet recruiting | Phase 2 | 53 | Fudan UniversityOTHER | 0 | May 18, 2025 | clinicaltrials |
| NCT06975462 | A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases | not yet recruiting | Phase 2 | 30 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | May 16, 2025 | clinicaltrials |
| NCT06975475 | SHR-A1811 and THPy in First or Second Line for HER2 Positive Advanced Breast Cancer Brain Metastases | not yet recruiting | Phase 2 | 60 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | May 16, 2025 | clinicaltrials |
| NCT06976021 | Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy(INTROSPECTION) | not yet recruiting | Phase 2 | 60 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 0 | May 16, 2025 | clinicaltrials |
| NCT06965556 | Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage(PE-CAT) | not yet recruiting | N/A | 1,138 | Fudan UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06956443 | Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction | not yet recruiting | — | 50 | University Medical Center GroningenOTHER | 0 | May 4, 2025 | clinicaltrials |
| NCT06950671 | Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study | not yet recruiting | — | 1 | Rahma Esam Salama EsawiOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06952270 | Effects of Two Strength Exercise Programs on Upper Limb Functionality in Breast Cancer | not yet recruiting | N/A | 24 | University of VigoOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06948539 | To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors | not yet recruiting | Phase 1 | 66 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06937281 | SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors(SABR PRIMER) | not yet recruiting | N/A | 40 | British Columbia Cancer AgencyOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06941142 | A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer | not yet recruiting | Phase 1 | 382 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Apr 23, 2025 | clinicaltrials |
| NCT06223698 | Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer(SWE-Switch) | not yet recruiting | Phase 3 | 3,832 | Region Örebro CountyOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT06934733 | The Efficacy of Oral Cryotherapy in Preventing TROP2-ADC-Induced Oral Mucositis in Patients With Advanced Breast Cancer | not yet recruiting | N/A | 124 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 18, 2025 | clinicaltrials |
| NCT06929325 | Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors | not yet recruiting | Phase 3 | 312 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06920108 | TRACE4BUS for BI-RADS Classification | not yet recruiting | — | 590 | DeepTrace Technologies S.r.l.INDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06910280 | Evaluation of the Feasibility of a Study Comparing Local Anesthesia and General Anesthesia in Conservative Surgery for Breast Cancer(ESCAL) | not yet recruiting | N/A | 60 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06909032 | Accelerated Partial Breast Irradiation Using External Beam Volumetric Modulated Arc Therapy (VMAT): a Randomised Non-inferiority Trial of 30 Gy Versus 26 Gy in Five Fractions Investigating Patient-reported Outcomes(PUMA) | not yet recruiting | N/A | 168 | Integrated Community Oncology NetworkOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06903429 | Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery(LUCAS) | not yet recruiting | N/A | 330 | Kyungpook National University Chilgok HospitalOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06632405 | A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC | not yet recruiting | Phase 2 | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Mar 26, 2025 | clinicaltrials |
| NCT06788197 | A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients | not yet recruiting | Phase 1 / Phase 2 | 52 | Henan Cancer HospitalOTHER_GOV | 0 | Mar 26, 2025 | clinicaltrials |
| NCT06893770 | The Effect of the Quran on Quality of Life and Quality of Sleep in Breast Cancer | not yet recruiting | N/A | 40 | Ardahan UniversityOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06775236 | Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 410 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 0 | Mar 19, 2025 | clinicaltrials |
| NCT06883877 | The Effect of a Multi-modal Program on Fear of Cancer Recurrence in Breast Cancer Patients | not yet recruiting | N/A | 84 | LIU WEIMINOTHER | 0 | Mar 19, 2025 | clinicaltrials |
| NCT06810492 | The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment | not yet recruiting | N/A | 40 | Hongmei Zheng, PhDOTHER | 0 | Mar 17, 2025 | clinicaltrials |
| NCT06664892 | Ultrahypofractionated Whole Breast Radiation Following Chemotherapy | not yet recruiting | N/A | 213 | MetroHealth Medical CenterOTHER | 0 | Mar 14, 2025 | clinicaltrials |
| NCT06871501 | "Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"(GIM29-GIMOMIC) | not yet recruiting | — | 1,000 | Consorzio OncotechOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06756295 | A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)(FAST-CR) | not yet recruiting | Early Phase 1 | 154 | Fengming KongOTHER | 0 | Mar 12, 2025 | clinicaltrials |
| NCT06868017 | Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles | not yet recruiting | Phase 4 | 208 | The First Hospital of Jilin UniversityOTHER | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06860217 | Robotic Nipple Sparing Mastectomy with Immediate Reconstruction | not yet recruiting | N/A | 24 | European Institute of OncologyOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06283511 | Evaluation of the RESTART Survival Programme | not yet recruiting | — | 200 | Jules Bordet InstituteOTHER | 0 | Feb 28, 2025 | clinicaltrials |
| NCT06849492 | HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer(SHIFT-001) | not yet recruiting | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Feb 27, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jun 13, 2025source: clinicaltrials